Pier Capital, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 179 filers reported holding HERON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.5%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$7,674,000
+53.4%
326,574
+20.8%
1.26%
+48.2%
Q3 2019$5,002,000
+3.3%
270,389
+3.8%
0.85%
+13.1%
Q2 2019$4,843,000
-26.5%
260,490
-3.3%
0.75%
-26.7%
Q1 2019$6,587,000
+0.1%
269,514
+6.3%
1.02%
-21.7%
Q4 2018$6,578,000
-20.7%
253,600
-3.2%
1.30%
+24.8%
Q3 2018$8,291,000261,9701.05%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders